Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
Urinary homovanillic acid (HVA) and vanillylmandelic acid (VMA) levels were determined in random samples and in 24-hour collections from 13 patients with neuroblastoma and 22 patients without neuroblastoma. Random sample levels were compared with levels in 24-hour collections and showed a positive correlation of 95% for HVA (N = 59) and 93% for VMA (N = 52). No false positives or false negatives occurred using random samples for diagnosis. Nonneuroblastoma (normal) HVA (N = 126) and VMA (N = 119) levels are reported for different age groups. Sequential random HVA and VMA determinations in patients with neuroblastoma during and after therapy are shown. Random urinary HVA and VMA levels are shown to be adequate for utilization in the diagnosis of neuroblastoma and sequential determinations of random HVA and VMA are shown to be helpful in the follow-up of those patients.
D000293:Adolescent; D002395:Catecholamines / Q000652:urine; D002648:Child; D002675:Child, Preschool; D006719:Homovanillic Acid / Q000652:urine*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009432:Neural Crest; D009447:Neuroblastoma / Q000652:urine*; D010648:Phenylacetates / Q000652:urine*; D011897:Random Allocation; D012016:Reference Values; D013997:Time Factors; D014642:Vanilmandelic Acid / Q000652:urine*
D002395:Catecholamines; D010648:Phenylacetates; D014642:Vanilmandelic Acid; D006719:Homovanillic Acid